JADE BIOSCIENCES INC (JBIO:NASDAQ)

$20.86 0.38 (1.8555%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed JADE BIOSCIENCES INC (JBIO:NASDAQ) News Sources

Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody

26-05-2026

yahoo.com

Assessing Jade Biosciences (JBIO) Valuation After Recent Share Price Weakness And Longer Term Gains

29-05-2026

yahoo.com

Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy

29-05-2026

yahoo.com

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

01-06-2026

yahoo.com

Jade Biosciences’ JADE101 Delivers Deep IgA Cuts, Clearing Path for Kidney Trials

02-06-2026

marketbeat.com

Jade Biosciences Announces Proposed Underwritten Public Offering

03-06-2026

yahoo.com

Jade Biosciences Announces Pricing of Public Offering of Common Stock

04-06-2026

yahoo.com

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

05-06-2026

yahoo.com

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors

26-06-2026

yahoo.com

Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market?

30-06-2026

yahoo.com

JADE BIOSCIENCES INC (JBIO:NASDAQ) Sentiment Trend

0 25 50 75 100 74 63 72 69 83 68 74 49 77 92 26-05-2026 29-05-2026 01-06-2026 02-06-2026 03-06-2026 04-06-2026 05-06-2026 26-06-2026 30-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

JADE BIOSCIENCES INC (JBIO:NASDAQ) FAQs

toggle

What is the current price of JADE BIOSCIENCES INC (JBIO:NASDAQ)?

The current price of JADE BIOSCIENCES INC (JBIO:NASDAQ) is $20.86.


toggle

JADE BIOSCIENCES INC (JBIO:NASDAQ) absolute price change since previous trading day?

The absolute price change of JADE BIOSCIENCES INC (JBIO:NASDAQ) since the previous trading day is $0.38.


toggle

JADE BIOSCIENCES INC (JBIO:NASDAQ) percentage price change since previous trading day?

The percentage price change of JADE BIOSCIENCES INC (JBIO:NASDAQ) since the previous trading day is 1.8555%.


toggle

What is the most recent average sentiment score for JADE BIOSCIENCES INC (JBIO:NASDAQ)?

The most recent average sentiment score for JADE BIOSCIENCES INC (JBIO:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for JADE BIOSCIENCES INC (JBIO:NASDAQ)?

The most recent sentiment for JADE BIOSCIENCES INC (JBIO:NASDAQ) is .


SEC-8K** Filing Available For JADE BIOSCIENCES INC (JBIO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.